$484 Million is the total value of Samsara BioCapital, LLC's 56 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 55.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | ARCELLX INC | $28,024,129 | -5.5% | 909,579 | -5.0% | 5.79% | -9.3% | |
| ISEE | Sell | IVERIC BIO INC | $16,710,696 | -3.4% | 686,835 | -15.0% | 3.45% | -7.2% |
| Sell | HILLEVAX INC | $10,081,019 | -1.2% | 609,862 | -0.0% | 2.08% | -5.1% | |
| BCEL | Sell | ATRECA INC | $299,623 | -5.7% | 262,827 | -33.8% | 0.06% | -8.8% |
| NVAX | Exit | NOVAVAX INCcall | $0 | – | -23,400 | -100.0% | -0.05% | – |
| KALA | Exit | KALA PHARMACEUTICALS INC | $0 | – | -12,024 | -100.0% | -0.10% | – |
| SWTX | Exit | SPRINGWORKS THERAPEUTICS INC | $0 | – | -22,204 | -100.0% | -0.12% | – |
| ALBO | Exit | ALBIREO PHARMA INC | $0 | – | -100,000 | -100.0% | -0.46% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -1,620,687 | -100.0% | -2.74% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.